• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔和奥密克戎变异株免疫逃逸的评估

Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants.

作者信息

Chaudhari Armi M, Joshi Madhvi, Kumar Dinesh, Patel Amrutlal, Lokhande Kiran Bharat, Krishnan Anandi, Hanack Katja, Filipek Slawomir, Liepmann Dorian, Renugopalakrishnan Venkatesan, Paulmurugan Ramasamy, Joshi Chaitanya

机构信息

Gujarat Biotechnology Research Centre (GBRC), Department of Science and Technology, Government of Gujarat, Gandhinagar 382011, India.

Cellular Pathway Imaging Laboratory (CPIL), Department of Radiology, Stanford University School of Medicine, Palo Alto, CA 94304, United States.

出版信息

Comput Struct Biotechnol J. 2022;20:4501-4516. doi: 10.1016/j.csbj.2022.08.010. Epub 2022 Aug 8.

DOI:10.1016/j.csbj.2022.08.010
PMID:35965661
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9359593/
Abstract

Emerging SARS-CoV-2 variants with higher transmissibility and immune escape remain a persistent threat across the globe. This is evident from the recent outbreaks of the Delta (B.1.617.2) and Omicron variants. These variants have originated from different continents and spread across the globe. In this study, we explored the genomic and structural basis of these variants for their lineage defining mutations of the spike protein through computational analysis, protein modeling, and molecular dynamic (MD) simulations. We further experimentally validated the importance of these deletion mutants for their immune escape using a pseudovirus-based neutralization assay, and an antibody (4A8) that binds directly to the spike protein's NTD. Delta variant with the deletion and mutations in the NTD revealed a better rigidity and reduced flexibility as compared to the wild-type spike protein (Wuhan isolate). Furthermore, computational studies of 4A8 monoclonal antibody (mAb) revealed a reduced binding of Delta variant compared to the wild-type strain. Similarly, the MD simulation data and virus neutralization assays revealed that the Omicron also exhibits immune escape, as antigenic beta-sheets appear to be disrupted. The results of the present study demonstrate the higher possibility of immune escape and thereby achieved better fitness advantages by the Delta and Omicron variants, which warrants further demonstrations through experimental evidences. Our study, based on computational modelling, simulations, and pseudovirus-based neutralization assay, highlighted and identified the probable mechanism through which the Delta and Omicron variants are more pathogenically evolved with higher transmissibility as compared to the wild-type strain.

摘要

具有更高传播性和免疫逃逸能力的新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变种在全球范围内仍然是一个持续存在的威胁。最近德尔塔(B.1.617.2)和奥密克戎变种的爆发就证明了这一点。这些变种起源于不同大陆并在全球传播。在本研究中,我们通过计算分析、蛋白质建模和分子动力学(MD)模拟,探索了这些变种刺突蛋白的谱系定义突变的基因组和结构基础。我们还使用基于假病毒的中和试验以及直接结合刺突蛋白N端结构域(NTD)的抗体(4A8),通过实验验证了这些缺失突变体对于免疫逃逸的重要性。与野生型刺突蛋白(武汉分离株)相比,NTD有缺失和突变的德尔塔变种显示出更好 的刚性和更低的灵活性。此外,对4A8单克隆抗体(mAb)的计算研究表明,与野生型菌株相比,德尔塔变种的结合减少。同样,MD模拟数据和病毒中和试验表明,奥密克戎也表现出免疫逃逸,因为抗原性β折叠似乎被破坏。本研究结果表明,德尔塔和奥密克戎变种具有更高的免疫逃逸可能性,从而获得了更好的适应性优势,这需要通过实验证据进行进一步论证。我们基于计算建模、模拟和基于假病毒的中和试验的研究,突出并确定了德尔塔和奥密克戎变种与野生型菌株相比更具致病性进化且传播性更高的可能机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/280700ab535c/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/64c85341370c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/4a6b2253b4cb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/90c4d650df80/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/eb7da7685602/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/dbcf17f7e2ae/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/1d60d0d216b6/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/48a7a00e4ac1/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/bc28c26f39d0/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/813469d469ca/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/3006de309072/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/280700ab535c/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/64c85341370c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/4a6b2253b4cb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/90c4d650df80/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/eb7da7685602/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/dbcf17f7e2ae/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/1d60d0d216b6/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/48a7a00e4ac1/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/bc28c26f39d0/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/813469d469ca/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/3006de309072/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f5c/9421312/280700ab535c/gr10.jpg

相似文献

1
Evaluation of immune evasion in SARS-CoV-2 Delta and Omicron variants.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔和奥密克戎变异株免疫逃逸的评估
Comput Struct Biotechnol J. 2022;20:4501-4516. doi: 10.1016/j.csbj.2022.08.010. Epub 2022 Aug 8.
2
Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19)严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新变种及针对冠状病毒(COVID-19)的新型疗法
3
Wild-type SARS-CoV-2 neutralizing immunity decreases across variants and over time but correlates well with diagnostic testing.野生型 SARS-CoV-2 中和抗体的免疫活性会随着时间推移和变异株的不同而降低,但与诊断检测有很好的相关性。
Front Immunol. 2023 Feb 8;14:1055429. doi: 10.3389/fimmu.2023.1055429. eCollection 2023.
4
Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants.开发针对包含奥密克戎的 SARS-CoV-2 变异株的假病毒中和测定法。
Viruses. 2022 Jun 18;14(6):1332. doi: 10.3390/v14061332.
5
Epistasis at the SARS-CoV-2 Receptor-Binding Domain Interface and the Propitiously Boring Implications for Vaccine Escape.SARS-CoV-2 受体结合域界面的上位性作用及对疫苗逃逸的有利影响
mBio. 2022 Apr 26;13(2):e0013522. doi: 10.1128/mbio.00135-22. Epub 2022 Mar 15.
6
Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability.新型冠状病毒XEC变异株N端结构域糖基化突变在免疫逃逸、细胞间融合及刺突蛋白稳定性中的作用
J Virol. 2025 Apr 15;99(4):e0024225. doi: 10.1128/jvi.00242-25. Epub 2025 Mar 26.
7
The Increased Amyloidogenicity of Spike RBD and pH-Dependent Binding to ACE2 May Contribute to the Transmissibility and Pathogenic Properties of SARS-CoV-2 Omicron as Suggested by In Silico Study.根据计算机研究表明,棘突 RBD 增加的淀粉样变性和对 ACE2 的 pH 依赖性结合可能导致 SARS-CoV-2 奥密克戎的传染性和致病性。
Int J Mol Sci. 2022 Nov 4;23(21):13502. doi: 10.3390/ijms232113502.
8
AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance.AlphaFold2 对 SARS-CoV-2 刺突奥密克戎 JN.1、KP.2 和 KP.3 变体构象集合的建模和分子动力学模拟:结合能突变分析揭示 ACE2 亲和力的上位驱动因素和抗体耐药性逃逸热点。
Viruses. 2024 Sep 13;16(9):1458. doi: 10.3390/v16091458.
9
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.关注的新冠病毒变异株的生物学功能及临床意义
Front Med (Lausanne). 2022 May 20;9:849217. doi: 10.3389/fmed.2022.849217. eCollection 2022.
10
The influence of new SARS-CoV-2 variant Omicron (B.1.1.529) on vaccine efficacy, its correlation to Delta variants: A computational approach.新型 SARS-CoV-2 变异株奥密克戎(B.1.1.529)对疫苗效力的影响,及其与德尔塔变异株的相关性:一种计算方法。
Microb Pathog. 2022 Aug;169:105619. doi: 10.1016/j.micpath.2022.105619. Epub 2022 Jun 8.

引用本文的文献

1
Temporal dynamics of SARS-CoV-2 phylogenetic diversity in Central Brazil reveals evolutionary shifts among variants of concern during the pandemic.巴西中部地区新冠病毒系统发育多样性的时间动态揭示了疫情期间受关注变异株之间的进化转变。
Front Microbiol. 2025 Aug 13;16:1639187. doi: 10.3389/fmicb.2025.1639187. eCollection 2025.
2
The pan-variant potential of light: 425 nm light inactivates SARS-CoV-2 variants of concern and non-cytotoxic doses reduce viral titers in human airway epithelial cells.光的泛变体潜力:425纳米的光可使新冠病毒变异株失活,且非细胞毒性剂量可降低人气道上皮细胞中的病毒滴度。
mSphere. 2025 Jun 25;10(6):e0023025. doi: 10.1128/msphere.00230-25. Epub 2025 May 28.
3

本文引用的文献

1
Insights into the structural peculiarities of the N-terminal and receptor binding domains of the spike protein from the SARS-CoV-2 Omicron variant.深入了解 SARS-CoV-2 奥密克戎变异株刺突蛋白 N 端和受体结合结构域的结构特点。
Comput Biol Med. 2022 Aug;147:105735. doi: 10.1016/j.compbiomed.2022.105735. Epub 2022 Jun 22.
2
Structural Dynamics of the SARS-CoV-2 Spike Protein: A 2-Year Retrospective Analysis of SARS-CoV-2 Variants (from Alpha to Omicron) Reveals an Early Divergence between Conserved and Variable Epitopes.SARS-CoV-2 刺突蛋白的结构动力学:对 SARS-CoV-2 变异株(从阿尔法到奥密克戎)的 2 年回顾性分析显示,保守和可变表位之间存在早期分化。
Molecules. 2022 Jun 15;27(12):3851. doi: 10.3390/molecules27123851.
3
In depth sequencing of a serially sampled household cohort reveals the within-host dynamics of Omicron SARS-CoV-2 and rare selection of novel spike variants.
对一个连续采样的家庭队列进行深度测序,揭示了奥密克戎SARS-CoV-2在宿主内的动态变化以及新型刺突变异株的罕见选择。
PLoS Pathog. 2025 Apr 28;21(4):e1013134. doi: 10.1371/journal.ppat.1013134. eCollection 2025 Apr.
4
Regional dynamics and mechanisms behind SARS-CoV-2 XDV.1 prevalence in Chongqing via genomic surveillance and molecular insights.通过基因组监测和分子洞察揭示重庆地区新冠病毒XDV.1毒株流行背后的区域动态及机制
Virus Res. 2025 May;355:199562. doi: 10.1016/j.virusres.2025.199562. Epub 2025 Mar 24.
5
In depth sequencing of a serially sampled household cohort reveals the within-host dynamics of Omicron SARS-CoV-2 and rare selection of novel spike variants.对一个连续采样的家庭队列进行深度测序,揭示了奥密克戎SARS-CoV-2在宿主内的动态变化以及新型刺突变异株的罕见选择。
bioRxiv. 2024 Nov 22:2024.11.21.624722. doi: 10.1101/2024.11.21.624722.
6
Genomic Surveillance and Molecular Characterization of SARS-CoV-2 Variants During the Peak of the Pandemic in Türkiye.土耳其疫情高峰期新冠病毒变异株的基因组监测与分子特征分析
Biochem Genet. 2024 Nov 8. doi: 10.1007/s10528-024-10962-8.
7
T Cell Peptide Prediction, Immune Response, and Host-Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects.T 细胞肽预测、免疫反应以及接种疫苗和从轻度 COVID-19 中康复的受试者中的宿主-病原体关系。
Biomolecules. 2024 Sep 26;14(10):1217. doi: 10.3390/biom14101217.
8
Dynamic expedition of leading mutations in SARS-CoV-2 spike glycoproteins.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突糖蛋白主要突变的动态研究
Comput Struct Biotechnol J. 2024 May 24;23:2407-2417. doi: 10.1016/j.csbj.2024.05.037. eCollection 2024 Dec.
9
Development and utility of a SARS-CoV-2 pseudovirus assay for compound screening and antibody neutralization assays.用于化合物筛选和抗体中和试验的新型冠状病毒2型假病毒检测方法的开发与应用
Heliyon. 2024 May 19;10(10):e31392. doi: 10.1016/j.heliyon.2024.e31392. eCollection 2024 May 30.
10
Exploration of phytochemical compounds against Marburg virus using QSAR, molecular dynamics, and free energy landscape.利用定量构效关系、分子动力学和自由能景观探索抗马尔堡病毒的植物化学化合物。
Mol Divers. 2024 Oct;28(5):3261-3278. doi: 10.1007/s11030-023-10753-0. Epub 2023 Nov 5.
Perspectives: SARS-CoV-2 Spike Convergent Evolution as a Guide to Explore Adaptive Advantage.
观点:SARS-CoV-2 刺突蛋白趋同进化可作为探索适应性优势的指导。
Front Cell Infect Microbiol. 2022 May 27;12:748948. doi: 10.3389/fcimb.2022.748948. eCollection 2022.
4
Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment.Omicron (BA.1)及其子变体(BA.1.1、BA.2 和 BA.3)对 SARS-CoV-2 刺突的感染性和致病性:基于序列和结构的比较计算评估。
J Med Virol. 2022 Oct;94(10):4780-4791. doi: 10.1002/jmv.27927. Epub 2022 Jun 16.
5
Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages.SARS-CoV-2 奥密克戎 BA.1、BA.1.1、BA.2 和 BA.3 亚谱系的抗体逃逸。
Cell Host Microbe. 2022 Aug 10;30(8):1077-1083.e4. doi: 10.1016/j.chom.2022.05.001. Epub 2022 May 8.
6
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.SARS-CoV-2 奥密克戎 BA.2 刺突的病毒学特征。
Cell. 2022 Jun 9;185(12):2103-2115.e19. doi: 10.1016/j.cell.2022.04.035. Epub 2022 May 2.
7
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.严重急性呼吸综合征冠状病毒2型奥密克戎BA.1和BA.2变体的中和作用
N Engl J Med. 2022 Apr 21;386(16):1579-1580. doi: 10.1056/NEJMc2201849. Epub 2022 Mar 16.
8
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.抗病毒药物对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎亚型BA.2的疗效
N Engl J Med. 2022 Apr 14;386(15):1475-1477. doi: 10.1056/NEJMc2201933. Epub 2022 Mar 9.
9
Boosting immunity to Omicron.增强对奥密克戎的免疫力。
Nat Med. 2022 Mar;28(3):445-446. doi: 10.1038/s41591-022-01727-0.
10
Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients.新冠疫苗接种者中不同的 SARS-CoV-2 奥密克戎反应性 T 和 B 细胞应答。
Sci Immunol. 2022 Mar 25;7(69):eabo2202. doi: 10.1126/sciimmunol.abo2202.